Healthcare / Medical DevicesNasdaqGM
$18.35
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-18.3M · quality 35.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
9/100
F
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$623M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-112.8%
↓Gross Margin
77.2%
↑Debt/Equity
3.09
↑Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2020–2025 · 5 años de histórico normalizado
Revenue CAGR
+19.4%
FCF CAGR
—
FCF margin
-11.3%
FCF / Net income
0.53x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $100.0M · net income $-21.5M · FCF $-11.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | $100.0M | $100.0M | $79.9M | $65.4M | $45.5M | $45.2M | $41.1M |
| Net Income | $-21.5M | $-21.5M | $-27.1M | $-33.0M | $-47.1M | $-36.1M | $-24.3M |
| EPS | -0.66 | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 | -117.85 |
| Gross Margin | 77.2% | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% | 73.6% |
| Operating Margin | -16.3% | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% | -31.7% |
| Net Margin | -21.5% | -21.5% | -34.0% | -50.4% | -103.4% | -79.9% | -59.0% |
| Balance Sheet | |||||||
| Debt/Equity | 3.09 | 3.09 | 7.43 | 2.76 | 1.52 | 0.68 | -0.34 |
| Cash Flow | |||||||
| Free Cash Flow | $-11.3M | $-11.3M | $-18.3M | $-19.9M | $-37.5M | $-25.0M | $-21.7M |
| Returns | |||||||
| ROE | -112.8% | -112.8% | -338.7% | -159.6% | -135.4% | -49.1% | 16.4% |
| Growth & Yield | |||||||
| Revenue Growth | 25.1% | 25.1% | 22.1% | 43.7% | 0.7% | 9.8% | — |
| EPS Growth | 29.0% | 29.0% | 26.8% | 33.5% | 12.0% | 98.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.